{"id":"https://openalex.org/W2897899486","doi":"https://doi.org/10.1016/j.jalz.2018.06.241","title":"P1\u2010236: A\u03b2 OLIGOMERS IMPAIR PLASTICITY BY DYSREGULATING MIR\u2010181A IN PRIMARY HIPPOCAMPAL CULTURES","display_name":"P1\u2010236: A\u03b2 OLIGOMERS IMPAIR PLASTICITY BY DYSREGULATING MIR\u2010181A IN PRIMARY HIPPOCAMPAL CULTURES","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2897899486","doi":"https://doi.org/10.1016/j.jalz.2018.06.241","mag":"2897899486"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2018.06.241","doi":"https://doi.org/10.1016/j.jalz.2018.06.241","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.241","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078725664","display_name":"Carlos J. Rodr\u00edguez\u2010Ortiz","orcid":"https://orcid.org/0000-0003-2688-947X","observed_orcids":["https://orcid.org/0000-0003-2688-947X"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Carlos J. Rodriguez-Ortiz","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047631640","display_name":"G. Aleph Prieto","orcid":"https://orcid.org/0000-0001-9517-6989","observed_orcids":["https://orcid.org/0000-0001-9517-6989"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Aleph Prieto","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109127771","display_name":"Carl W. Cotman","orcid":"https://orcid.org/0000-0001-6533-9062","observed_orcids":["https://orcid.org/0000-0001-6533-9062"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carl W. Cotman","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009317100","display_name":"Masashi Kitazawa","orcid":"https://orcid.org/0000-0003-2165-8197","observed_orcids":["https://orcid.org/0000-0003-2165-8197"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masashi Kitazawa","raw_affiliation_strings":["University of California, Irvine, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Irvine, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078725664"],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17031266,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"7S_Part_6","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyloid-beta-oligomers","display_name":"amyloid-beta oligomers","score":0.921999990940094},{"id":"https://openalex.org/keywords/mir-181a","display_name":"miR-181a","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C25274449","wikidata":"https://www.wikidata.org/wiki/Q1805481","display_name":"Long-term potentiation","level":3,"score":0.7374110221862793},{"id":"https://openalex.org/C148762608","wikidata":"https://www.wikidata.org/wiki/Q3748185","display_name":"Hippocampal formation","level":2,"score":0.7270231246948242},{"id":"https://openalex.org/C98229152","wikidata":"https://www.wikidata.org/wiki/Q1551556","display_name":"Synaptic plasticity","level":3,"score":0.7217211723327637},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5109009146690369},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4940250515937805},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.480564147233963},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.45388513803482056},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.43610015511512756},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4143597483634949},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3230586647987366},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2359515130519867},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07123631238937378},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2018.06.241","doi":"https://doi.org/10.1016/j.jalz.2018.06.241","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.241","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3008609356","https://openalex.org/W2980827562","https://openalex.org/W4206129026","https://openalex.org/W1555289101","https://openalex.org/W302691769","https://openalex.org/W1993231594","https://openalex.org/W1637989849","https://openalex.org/W4388310076","https://openalex.org/W2883956969","https://openalex.org/W2807946721"],"abstract_inverted_index":{"Deposit":[0],"of":[1,37,71,92,122,141,254,283,292,302,306,313,329,342],"amyloid-beta":[2],"(A\u03b2)":[3],"has":[4,73],"been":[5,74],"regarded":[6],"as":[7],"the":[8,50,90,265],"initial":[9],"pathological":[10],"hallmark":[11],"in":[12,89,95,128,148,244,346],"Alzheimer's":[13],"disease":[14],"(AD),":[15],"and":[16,39,41,54,69,108,125,159,234,261,269,286,304,309,331],"it":[17],"is":[18,86,325],"now":[19],"well":[20],"accepted":[21],"that":[22,48,84,115,296,323],"soluble":[23,155,337],"A\u03b2":[24,338],"oligomers":[25,339],"(A\u03b2o),":[26],"rather":[27],"than":[28],"fibrillary":[29],"A\u03b2,":[30],"primarily":[31],"mediate":[32,66],"neurotoxic":[33],"effects":[34,56],"including":[35,258],"loss":[36],"synapses,":[38],"plasticity":[40,101,129,345],"memory":[42],"impairments.":[43,130],"However,":[44],"specific":[45],"cellular":[46],"mechanisms":[47],"explain":[49],"link":[51],"between":[52],"A\u03b2o":[53,116,156,297],"these":[55],"remain":[57],"to":[58,65,76,78,104,120,214,225],"be":[59],"determined.":[60],"Recently,":[61],"microRNAs":[62,72],"were":[63,166,188,200,271],"found":[64,238],"synaptic":[67,161,266,344],"plasticity,":[68,330],"dysregulation":[70],"reported":[75],"contribute":[77],"AD":[79],"neuropathology.":[80],"Previously,":[81],"we":[82,113,135,152,228,294],"identified":[83],"miR-181a":[85,118,147,158,221,233,241,256,277,303,314,324],"significantly":[87,298],"increased":[88,251],"hippocampus":[91],"3xTg-AD":[93],"mice":[94],"a":[96,289,326],"pathology-dependent":[97],"manner.":[98],"MiR-181a":[99,247],"regulates":[100,232],"by":[102,146,182,336],"binding":[103],"several":[105,255],"plasticity-related":[106,142],"mRNAs":[107],"repressing":[109],"their":[110],"translation.":[111],"Therefore,":[112],"hypothesize":[114],"dysregulate":[117],"leading":[119],"repression":[121],"downstream":[123,235],"targets":[124,257],"ultimately":[126],"resulting":[127],"To":[131],"test":[132],"this":[133],"hypothesis,":[134],"first":[136],"determined":[137,295],"whether":[138,154,230],"activity-dependent":[139],"induction":[140,216],"proteins":[143,267],"was":[144,176],"mediated":[145,340],"hippocampal":[149,164,245,348],"cultures.":[150,246,349],"Second,":[151],"evaluated":[153],"upregulate":[157],"produced":[160],"abnormalities.":[162],"Primary":[163],"cultures":[165],"obtained":[167],"from":[168],"P0":[169],"C57BL/6J":[170],"mice.":[171],"Chemical":[172],"long-term":[173],"potentiation":[174],"(cLTP)":[175],"induced":[177],"on":[178,240],"12-14":[179],"day-old":[180],"cells":[181],"0.2mM":[183],"glycine":[184],"for":[185,191,202],"10min.":[186],"Cultures":[187,199],"then":[189],"processed":[190],"Taqman":[192],"qPCR":[193],"or":[194],"immunoblot":[195],"1hr":[196],"after":[197,242,273],"cLTP.":[198,226,274],"treated":[201],"2hrs":[203],"with":[204,219,250,276],"100nM":[205],"amyloid":[206],"beta-derived":[207],"diffusible":[208],"ligands":[209],"1-42":[210],"(ADDLs,":[211],"A\u03b2o)":[212],"prior":[213,224],"cLTP":[215,231,243],"and/or":[217],"transfected":[218],"15nM":[220],"mimics/inhibitors":[222],"48hrs":[223],"First,":[227],"examined":[229],"targets.":[236],"We":[237],"reduction":[239,301],"downregulation":[248],"correlated":[249],"protein":[252],"levels":[253],"GluA2,":[259,307],"CaMKII,":[260,308],"cFos.":[262,310],"In":[263,288],"addition,":[264],"PSD95":[268],"synaptophisin":[270],"upregulated":[272],"Co-treatment":[275],"mimics":[278],"effectively":[279],"reversed":[280],"cLTP-induced":[281,300,343],"upregulation":[282,305],"cFos,":[284],"CaMKII":[285],"GluA2.":[287],"second":[290],"series":[291],"experiments,":[293],"impaired":[299],"Pharmacological":[311],"inhibition":[312],"markedly":[315],"rescued":[316],"A\u03b2o-mediated":[317],"synaptotoxicity.":[318],"Our":[319],"results":[320],"strongly":[321],"indicate":[322],"negative":[327],"regulator":[328],"its":[332],"abnormal":[333],"activation":[334],"elicited":[335],"impairment":[341],"primary":[347]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-10-26T00:00:00"}
